Evidence map›Paper›PMID 42206025›Full record

ArticleFrontiers in immunology2026

Chao An, Shanjian Chen, Anqi Zheng, Lingqi Zheng, Chenshuo Luo, Bin Yang, Yulan Lin

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in immunology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Chao AnDepartment of Clinical Laboratory, The First Affiliated Hospital, Fujian Medical University, Fuzhou, Fujian, China.
Shanjian ChenDepartment of Clinical Laboratory, The First Affiliated Hospital, Fujian Medical University, Fuzhou, Fujian, China.
Anqi ZhengDepartment of Clinical Laboratory, The First Affiliated Hospital, Fujian Medical University, Fuzhou, Fujian, China.
Lingqi ZhengDepartment of Clinical Laboratory, The First Affiliated Hospital, Fujian Medical University, Fuzhou, Fujian, China.
Chenshuo LuoDepartment of Clinical Laboratory, The First Affiliated Hospital, Fujian Medical University, Fuzhou, Fujian, China.
Bin YangDepartment of Clinical Laboratory, The First Affiliated Hospital, Fujian Medical University, Fuzhou, Fujian, China.
Yulan LinDepartment of Clinical Laboratory, The First Affiliated Hospital, Fujian Medical University, Fuzhou, Fujian, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objective: Methods: From October 2024 to January 2026, normal phenotype Results: A total of 46 Conclusion:

Indexed as

Persistent InfectionPneumonia, StaphylococcalPseudomonas InfectionsRespiratory Tract InfectionsStaphylococcal InfectionsStaphylococcus aureusAdultAnimalsAnti-Bacterial AgentsBiofilmsFemaleHumansMaleMiceMicrobial Sensitivity TestsMiddle AgedAnti-Bacterial Agentsbiofilmimmune evasionpulmonary infectionsmall colony variantsStaphylococcus aureus

Identifiers

PMID42206025
PMCPMC13201127

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.